**Core tip**: Percutaneous interventional radiologic gastrostomy has become a popular choice for gastrostomy placement. However, there hasn\'t been an established most-optimal percutaneous interventional radiologic gastrostomy method. Therefore, we would like to present what we believe is the best approach and hope to spark readers\' interests in pursuing further direct comparison studies.

INTRODUCTION
============

Gastrostomy catheters provide alternative feeding access for patients who cannot tolerate oral intake. Common feeding indications include head and neck tumors, complex postsurgical head and neck reconstructions, esophageal tumors, esophageal motility disorders and neurological disorders leading to dysphagia with a high risk of aspiration (*e.g*., amyotrophic lateral sclerosis, multiple sclerosis, stroke with residual impairment)\[[@B1]\]. Other conditions that may warrant gastrostomy catheters include severe gastroparesis and small bowel obstruction. For these indications, gastrostomy catheters are used to provide gastric decompression and palliation.

Gastrostomy catheters can be placed in a variety of ways. The three primary modalities include surgical, endoscopic and interventional radiologic placement. Each technique may be preferred under specific circumstances and is based on local expertise. There is ongoing debate with regard to the most optimal modality\[[@B2],[@B3]\]. Invasive surgical gastrostomy was first described in the 1800s and has a 100% technical success rate\[[@B4]\]. It is typically pursued through a left sagittal incision followed by a direct cut-down to the gastric body for access. A minimally invasive alternative is percutaneous endoscopic gastrostomy (PEG) which requires moderate conscious sedation and local anesthetics. Thereby, it minimizes the risk of cardiopulmonary compromise that is associated with general anesthesia. In comparison to surgical gastrostomy, PEG is much quicker and is performed in the endoscopy suites. Thus, the endoscopic approach negates the need for an expensive operating room. Further, in comparison to surgical gastrostomy, PEG has been reported to have decreased overall morbidity and mortality\[[@B2],[@B5]\]. However, there have been reports documenting inadvertent tumor metastasis to gastrostomy placement sites\[[@B6]\]. This phenomenon can be a result of tumor seeding from passing the rigid endoscope through malignancy located along the advancement path. With the advent of image guided techniques, percutaneous interventional radiological gastrostomy (PIRG) has become an evolving and attractive alternative. It circumvents some limitations of surgical and PEG approaches, such as tumor seeding, potential disruption of the postsurgical head and neck reconstruction zone or complications associated with invasive surgeries. In addition, PIRG can identify and assess for the location of surrounding structures using image guidance and colonic opacification. The use of these techniques decreases the risk of accidental organ injury and ultimately increases patient safety. On the other side, in comparison to PEG, PIRG required a dedicated fluoroscopy suite, which may not be readily available at all institutions. Further, institutional expertise in either PIRG or PEG may dictate the preference for either techniques due to complication rates and duration of the procedure.

Similar to PEG, PIRG can also be performed in either a "pull" or "push" technique\[[@B7],[@B8]\]. The "pull" PIRG technique is performed by advancing a needle into the air-insufflated stomach. A catheter is then advanced through the esophagus into the oral cavity *via* a retrograde approach. A guidewire is advanced through the catheter gaining through-and-through access. The gastrostomy catheter is fastened to the guidewire, and pulled antegrade through the mouth, esophagus, and abdominal wall. It is typically secured to the anterior abdominal wall utilizing a mushroom-retaining method. In our institution, we prefer the "push" PIRG technique. The purpose of this article is to present our institutional approach to "push" PIRG technique and the perioperative care of this patient population in a stepwise fashion.

PROCEDURE
=========

Prior to the procedure, a thorough pre-procedural assessment should be completed. If available, a recent computed tomography (CT) within the last two to four months should be reviewed to assess the gastric anatomy and the suitability of gastrostomy catheter placement. While evaluating the anatomy, it should be considered that after air insufflation, the anatomy can change markedly such that a previously inaccessible gastric body may become accessible. Therefore, if a prior CT is not available, it is not advisable to repeat the scan before the procedure. Instead a cone-beam CT can be performed after gastric insufflation to assess the anatomy as well as the chance of obtaining percutaneous access. Pre-procedure complete blood count and coagulation labs should be checked. Based on our institutional guidelines, platelets should be above 50 × 10^9^/L and international normalized ratio should be lower than 1.5. Other contraindications include uncorrectable coagulopathy, massive hepatosplenomegaly or anteriorly overlying colon preventing a safe access to the stomach, peritonitis, and bowel ischemia. Due to the risk of bleeding, access through omental implants should be avoided. Cone beam CT or available prior CT imaging is helpful to determine a safe direct access to the gastric body without intervening omental implants. If ascites is seen between the stomach and abdominal wall, a paracentesis should be performed at the day of procedure.

In the vast majority of cases, gastrostomy catheter placement can be pursued using moderate conscious sedation with intravenous fentanyl and midazolam administration. If the patient is unable to cooperate or is agitated during the procedure, general anesthesia may be considered.

Ideally a nasogastric tube (NGT) should be in place before the patient comes to the procedure room. However, in cases with challenging NGT placement, such as those with complex postsurgical head and neck reconstructions, the NGT can be placed under fluoroscopy guidance. A 4-French Kumpe or 5-French MPA catheter can be inserted through one of the nostrils over a hydrophilic guidewire (typically a 0.035-inch Glidewire) into the stomach. The guidewire is then removed and the 4-French Kumpe or 5-French MPA catheter remains in place to inflate the stomach with air. The Kumpe or MPA catheter needs to be threaded very cautiously in postsurgical head and neck patients. It should be placed under continuous fluoroscopy imaging to avoid damages to the post-surgical area, such as a complex reconstructed flap. Next, in the procedure suite a focused pre-procedural ultrasound must be performed to mark the edge of the left liver lobe and the location of the epigastric arteries. Both structures need to be avoided to decrease the risk of significant bleeding. Two g of intravenous cefazolin will be given to the patient immediately prior to the procedure as antibiotic prophylaxis. In cases of penicillin allergy, 1 g intravenous vancomycin or 600 mg intravenous clindamycin can be administered alternatively\[[@B9]\].

At the beginning of the procedure, the abdomen is prepared in the usual sterile fashion. The stomach is manually inflated with air to pitch the gastric body against the abdominal wall. If the stomach decompresses rapidly through peristalsis as evidenced on fluoroscopy, 1 mg of glucagon is given intravenously to decrease the peristaltic motion and thereby maintain the gastric insufflation. Optimal gastric insufflation is of the utmost importance to facilitate safe access, to reduce the risk of gastric tube misplacement, and to decrease the risk of accidental organ injuries. If there is any doubt about the safety of percutaneous access based on fluoroscopy, cone-beam CT can be performed. The access site is chosen under imaging guidance and should be half way between the greater and lesser gastric curvatures overlying the gastric body and should be angled towards the pylorus. The angled approach is advisable since it facilitates conversion to a gastrojejunostomy tube later if clinically warranted. Once the stomach is sufficiently inflated and the access site has been selected, the gastropexy is performed by using three T-bar fasteners in a triangular fashion around the selected percutaneous access site (Figure [1](#F1){ref-type="fig"}). The first T-bar fastener is lined up with the beam in the left anterior oblique view projecting over the gastric body. The T-bar fastener is advanced slowly under the fluoroscopic guidance until resistance is met. The prior CT or intra-procedural cone beam CT can help assess the distance needed to be traversed towards the gastric wall. The C-arm is then rotated to the right anterior oblique view to visualize the gastric wall tenting in real time and to assess the exact depth of the T-bar fastener. While tenting the gastric wall, the T-bar fastener is connected to an empty syringe and is advanced with continuous suction until air is aspirated into the syringe. Iodinated contrast is then injected to ascertain the intragastric location of the T-bar fastener, which is then released. This process is repeated with the second and third T-bar fastener.

![Schematic drawing of procedure planning for T-fasteners and percutaneous endoscopic gastrostomy entry sites. T-fasteners are positioned triangularly 1 inch away from each other. The ideal position should be half way between the lesser and greater curvatures. Catheter should enter in the center of the triangle and aim towards the pylorus.](WJG-26-383-g001){#F1}

Next, the actual percutaneous gastrostomy is performed. First an 18-gauge needle is lined up with the beam in the left anterior oblique view projecting over the gastric body at the selected entry site. The needle is angled towards to the antrum and pylorus and is advanced slowly under the fluoroscopic guidance until resistance is met. Again, the needle advancement distance to the gastric wall can be assessed on prior CT or intra-procedural cone-beam CT. The C-arm is then rotated to the right anterior oblique view to visualize gastric wall tenting in real-time and to assess the exact depth of the needle. While tenting the gastric wall the needle is connected to an empty syringe and is advanced under continuous mild suction until air is aspirated into the syringe. Iodinated contrast is then injected to ascertain the intragastric location of the needle. At this time, a 0.035-inch Amplatz stiff wire is advanced through the 18-gauge needle into the stomach. Subsequently, the needle is removed over the wire. After sequential dilation of the access site by stiff dilators, the peel-away sheath is advanced over the guidewire. This is followed by gastrostomy catheter placement over the Amplatz wire through the peel-away sheath. The peel-away sheath is four French larger than the gastrostomy catheter. We typically place a 16-French gastrostomy catheter which requires a 20-French peel-away sheath or an 18-French gastrostomy catheter which requires a 22-French peel-away sheath. As gastrostomy catheter we utilize a balloon-type silicone catheter with a large lumen instead of the smaller caliber pigtail catheter. Next, the balloon of the gastrostomy catheter is inflated with the maximal recommended amount of sterile water (which is usually 5 cc and 10 cc for the 16- and 18-French gastrostomy catheters. The gastrostomy catheter is pulled back until resistance is met and this essentially secures the intraluminal balloon against the lining of the near gastric wall. Finally, the Amplatz wire is removed and iodinated contrast is injected through the freshly placed gastrostomy catheter to ascertain location within the gastric body. The gastrostomy catheter is connected to a drainage bag (we typically use a Foley bag) to enable gravity drainage for 24 h before starting to use the gastrostomy catheter for enteral feeding. The main reason for 24-h passive drainage is to remove retained gastric products (potentially mixed with hemorrhagic products from the procedure).

Alternatively, the tract can be dilated with an angioplasty technique using balloons. When applying this technique, we typically use a 6 mm × 40 mm or 7 mm × 40 mm Mustang balloon (Boston Scientific, Natick, MA) to place a 16-French tube. After tract dilation the gastrostomy catheter can be advanced into the gastric body while deflating the angioplasty balloon. This method may result in a tighter gastrostomy catheter access tract thereby potentially preventing leakage in the future.

Special attention should be given when performing PIRG in patients with massive ascites. A paracentesis should be performed prior to the gastrostomy procedure to provide a favorable safe access. Once the gastrostomy catheter is placed, the tract should be allowed to mature for approximately 6 to 8 wk prior to any further tube manipulation as premature tube changes or gastrojejunostomy tube conversion is associated with a significant risk of losing access when ascites is present.

At 24-h post-procedure, a focused abdominal exam is performed to assess for peritoneal signs and associated potential malposition of the gastrostomy catheter on all patients. Potential hematoma formation is also assessed. Post-procedural complete blood count, such as hemoglobin, hematocrit and white blood cell, should be analyzed for potential bleeding and infection. If the abdominal exam is completely benign and the patient is asymptomatic, post-procedural complete blood count may not be required. A mild increase of the white blood cell count post procedure is frequently encountered and is not concerning. At this point, if the patient does not exhibit any signs of leak, infection or bleeding, a 2-h sterile water trial should be conducted. A 25 cc sterile water bolus is given in the first hour, followed by another 25 cc bolus in the second hour. If the patient tolerates the sterile water trial without any signs of peritoneal irritation or leakage, tube feeding can be started slowly. The procedure is tolerated well and typically no dedicated post-procedural pain management is needed.

The T-bar fasteners usually falls off after 2 to 3 wk. A follow-up appointment in the interventional radiology outpatient clinic is scheduled 3 wk post procedure to assess for gastrostomy catheter function and potential complaints. At that time, it is again checked whether all three T-bar fasteners fell off. If there is retained material it will be removed during the clinic visit. Newer T-bar fasteners are falling off without removal requirement. Seldom there is retained material which can be removed during the outpatient clinic visit. If gastrostomy catheter leakage is noticed during follow-up the gastrostomy catheter can be upsized to a larger caliber. Conservative alternatives for treatment of leakage are slowing down the tube feeds to a "trickle" fashion or placing the gastrostomy intermittently to suction to decompress the stomach. Further, in case of leakage it is important to ensure that the retention balloon is inflated at its maximum capacity and is firmly placed against the anterior abdominal wall. If the tract has matured for 6 to 8 weeks and leakage persists a conversion of the gastrostomy catheter to the gastrojejunostomy tube is recommended. In a gastrojejunostomy tube the jejunostomy lumen can be used for feeding purposes while the gastrostomy lumen is used for venting purposes and placed on suction to decompress the stomach.

Based on our experience the procedure is usually performed in less than 30 min with moderate conscious sedation under fluoroscopy guidance and less than 45 min under both fluoroscopy and cone beam CT guidance. The typical fluoroscopic time is between 5 to 7 min. Representative PIRG placement cases are shown in Figures [2](#F2){ref-type="fig"}-[4](#F4){ref-type="fig"} to demonstrate the said steps with fluoroscopy and procedure time.

![Eighty-one-year-old male with a past medical history of diabetes mellitus, hypertension, perforated diverticulitis status post resection with colostomy and adenocarcinoma of the esophagus status post neoadjuvant chemotherapy. Patient was admitted for failure to thrive and percutaneous gastrostomy tube placement was requested. An 18-French Entuit gastrostomy tube was placed within a 22-French peel-away sheath. The procedure time was 44 min. Fluoroscopy time was 8 min 6 s and Air Kerma was 280 mGy. This procedure was challenging due to the inability to keep the stomach inflated and glucagon was avoided given the medical history of diabetes mellitus. The gastrostomy tube was started to be used for enteral feeding 24 h after the procedure. A: Advancement of a 5-French MPA catheter (arrow) into the stomach along with a 0.035 Glidewire. The position of the MPA catheter was confirmed with a small amount of iodinated contrast injection; B: Insufflation of the stomach with air though the MPA catheter. A hemostat was used to mark the entry site; C: Placement of the three T-bar fasteners (arrows) as well as the gastrostomy tube with balloon inflated using a mixtures of sterile water with minimal amount of contrast (arrowhead); D: A post-procedural cone-beam computed tomography was performed due to the challenge of keeping the stomach insufflated with air. The cone beam computed tomography showed the gastrostomy tube with the inflated balloon (arrow) in the gastric body. Of note the gastrostomy balloon appears slightly radiopaque due to inflation using a mixture of sterile water with minimal amount of contrast. After completion of the procedure the 5-French MPA catheter was removed.](WJG-26-383-g002){#F2}

![Seventy-six-year-old female with a history of upper extremity edema, intracranial hemorrhage and dysphagia referred for placement of percutaneous gastrostomy tube due to dysphagia with high aspiration risk. A 16-French gastrostomy tube was placed through a 20-French peel-away sheath. The procedure time was 23 min. Fluoroscopy time was 3 min 24 s and Air Kerma was 43 mGy. No challenge was encountered during the procedure and the gastrostomy tube was started to be used for enteral feeding 24 h after the procedure. A: Dobhoff tube (arrowhead) with its tip in the gastric body was placed before the patient came to the procedure suite. The stomach was manually inflated with air. T-bar fasteners (white arrow) were advanced into the gastric body. Note the connected tubing (black arrow) which contained iodinated contrast; B: Iodinated contrast was injected into the gastric body through the T-bar fastener to confirm intraluminal location. Note the outlines of gastric rugae (black arrowheads); C: The three T-bar fasteners (white arrows) are positioned in a triangular fashion. Note the gastrostomy tube (black arrow) was angulated towards the antrum and pylorus facilitating later conversion to a gastrojejunostomy tube; D: Contrast injection through the gastrostomy tube ascertains the intragastric placement of the tube.](WJG-26-383-g003){#F3}

![Ninety-four-year-old female with a history of moderately differentiated adenocarcinoma of the esophagus referred for percutaneous gastrostomy tube placement. A 16-French gastrostomy tube was placed through a 20-French peel-away sheath. Procedure time was 21 min. Fluoroscopy time was 6 min 18 s and Air Kerma was 81.5 mGy. The gastrostomy tube was started to be used for enteral feeding 24 h after the procedure. A: A pre-procedural cone-beam CT was obtained since no CT abdomen was available. A 5-French MPA catheter was placed along with a 0.035 Glidewire. The stomach was manually inflated with air. Arrowhead points to a 21-gauge short local anesthetic needle left in place for entry site planning; B: Placement of the first T-bar fastener (white arrow). Again, note the inflated stomach (arrowheads); C: Note the three T-bar fasteners as linear densities (white arrows). An 18-French needle was visualized at the access site in the left anterior oblique projection lined. The needle (black arrow) was in line with the radiation beam and was aiming towards the antrum and pylorus; D: In the right anterior oblique projection, the depth of the needle (black arrow) can be visualized penetrating the gastric wall; E, F: With iodinated contrast injection, the gastric rugae (arrowheads) could be visualized, thus confirming the intragastric location of the needle; G: The advancement of the 0.035 Amplatz wire (arrowheads) over the needle was pursued. After subsequent tract dilatation the peel-way sheath (arrow) was advanced over the Amplatz; H: The gastrostomy tube (arrow) was advanced through the peel-away sheath. After completion of the procedure the MPA catheter was removed.](WJG-26-383-g004){#F4}

DISCUSSION
==========

Certain disease conditions require an alternative enteral feeding access. NGT can provide short-term access, but its long-term use is limited by patient discomfort and higher malposition and aspiration risk. Further, the postsurgical head and neck patient is not a candidate for NGT placement due to the risk of damaging the surgical field, such as a complex reconstruction flap. For patients with a functional gastrointestinal tract, total parenteral nutrition is not ideal due to a lack of bowel stimulation leading to a compromised gut defense barrier and high rates of infection\[[@B10]\]. Further, parenteral nutrition is costly. In certain patients the gastrostomy catheter can provide a durable solution for long-term feeding.

Since its inception in 1981, the PIRG technique has gradually improved and has become a safe and effective alternative to the traditional surgical or endoscopic gastrostomy catheter placements. It requires moderate conscious sedation and local anesthetics, thus minimizing the risks of cardiorespiratory compromise. Further, it is a relatively quick procedure that can be performed in the interventional radiology suite, which negates the need for an expensive operating room. The average cost of PIRG is comparable to or slightly cheaper than PEG and lower than surgical gastrostomy. Barkmeier et al\[[@B11]\] reported that the cost of PIRG to be \$1985 while that of PEG to be \$1862 in an United States institution while Galaski et al\[[@B12]\] reported \$407 for PIRG and \$591 for PEG in Canadian dollars. In addition, since it can be performed in a timely manner (the vast majority of PIRG procedures are below 30 min at our institution), scheduling is often more flexible as well.

Clinically, there are a limited number of absolute contraindications for PIRG, including active peritonitis, uncorrectable coagulopathy, and acute bowel ischemia (if the gastrostomy catheter is used for feeding purposes)\[[@B13]\]. Modifications and improvement of the current practice can avoid much of the technical difficulties. The use of image guided direct transabdominal access can avoid an obstructing neoplastic mass involving the pharynx, larynx, esophagus and stomach. The use of cone-beam CT in addition to fluoroscopic guidance in challenging cases can effectively identify the insufflated stomach and avoid needle punctures to the adjacent organs such as the colon, liver and spleen. In the past, colonic interposition was an absolute contraindication\[[@B1]\]. However, with fluoroscopic guidance, an infracolonic approach is feasible.

The technical success rate of PIRG is high. PIRG success rate ranges between 98%-100%\[[@B14]-[@B17]\]. In comparison, surgical gastrostomy has a 100% success rate due to the nature of the open approach\[[@B2]\]. PEG has a success rate ranging between 84%-96%\[[@B12],[@B18],[@B19]\]. The technical difficulties associated with PEG are largely due to inability to adequately transilluminate the anterior abdominal wall, such as in the case of morbidly obese patients. Local anatomical anomalies such as large hiatal hernia and obstructing oropharyngeal cancer are limiting the use of PEG. PIRG can be successfully performed in patients who have failed PEG attempts. Thornton et al\[[@B20]\] have reported that PIRG was attempted in forty-two patients who have failed PEG trial due to gastrointestinal obstruction, suboptimal transillumination, and cardiorespiratory decompensation. In this population forty-one patients underwent successful PIRG placement.

In addition to the high technical success rate, PIRG has low procedure-related mortality rates that is comparable to or better than other modalities. It is worth emphasizing that patients referred to PIRG are often ill and sometimes have failed previous PEG attempts. Bell et al\[[@B21]\] reported the 30-d mortality rate to be 17.1% in 416 patients, although only 2 of these patient deaths were procedure-related. Similarly, Ahmed et al\[[@B14]\] reported a 19.7% one-year mortality in 305 patients. Among those, only one procedure-related death occured. Further, Perona et al\[[@B15]\] reported a 0.2% procedure-related mortality rate over twelve years. Wollman et al\[[@B2]\] reported a procedure-related mortality rate of 0.3% for PIRG and 0.53% for PEG. A British meta-analysis has reported 1.8% and 2.2% of procedure-mortality for PIRG and PEG groups respectively in 2379 patients\[[@B22]\]. PIRG associated complications are generally divided into major and minor categories: major complications being abscess formation, bowel perforation, peritonitis, and hemorrhage while minor complications include superficial infection, tube dislodgement, tube occlusion and leakage. de Baere et al\[[@B17]\] reported 1.4% and 5.4% major and minor complications rates in five hundred patients. Similarly, Ahmed et al\[[@B14]\] reported 2% and 5% major and minor complication rates in 300 patients. Further, PEG and PIRG groups have comparable complication rates that are markedly lower than that of the surgical gastrostomy group. In an earlier meta-analysis, the surgical gastrostomy catheter group had a 29% overall complication rate while PEG and PIRG groups had 15.4% and 13.3%, respectively\[[@B2]\]. Barkmeier et al\[[@B12]\] reported five minor complications in forty-two PIRG patients and sixteen in forty-five PEG patients.

The most common major complications associated with PIRG are peritonitis and hemorrhage. Peritonitis occurs in approximately 1.3% of the patients\[[@B23]\]. Peritonitis can occur as a result of chemical irritation due to bowel content leakage from tube dislodgement, peritoneal catheterization, peritoneal iodinated contrast injection, colonic perforation or leakage around the puncture sites. Peritonitis can also occur due to bacterial infection from skin flora invasion through the catheterization track or from bowel content. Therefore, antibiotics prophylaxis is recommended. It is worth noting that peritonitis can potentially cause significant morbidity and mortality as this patient population tends to be frail\[[@B24],[@B25]\]. The newly placed gastrostomy catheter must be allowed to passive drainage for 24 h prior to the initiation of tube feeding to decompress the gastric body and minimize the risk of leakage. If per oral medication administration is required for certain patient populations a nasogatric tube should be used in the first 24 h. While giving the per oral medication the freshly placed gastrostomy catheter can be clamped for 30 to 60 min to enable absorption of the administered per oral medication before placing the gastrostomy catheter to passive drainage again. Specific attention must be given to assess for post-procedure peritonitis. Signs of peritonitis include fever, chills, tachycardia, hypotension, elevated white blood cell count, abdominal pain, and guarding/rebound tenderness on post procedure physical exam. Hemorrhage occurs in approximately 1.4% of all patients\[[@B23]\]. Large volume hemorrhage is rare unless the epigastric or gastroepiploic vessels are injured during the procedure. Therefore, it is important to assess the bowel and vascular anatomy with pre-procedural CT and ultrasound. Furthermore, it is critical to choose the initial gastrostomy site near the upper third of the abdomen to avoid the epigastric vessels. In addition, access site should be directed at the mid-section of the stomach equidistant from the greater and lesser curvatures to avoid the gastric and gastroepiploic vessels.

There has been a paucity of data comparing the two different PIRG techniques: the so-called "push" and "pull" techniques. A review of literature shows comparable major complication rates across both groups and either comparable or slightly lower minor complication rates in the "pull" group as compared to the "push" group\[[@B24],[@B26]-[@B28]\]. A detailed look into the studies has shown that the gastrostomy catheter used in the "push" group is consistently smaller in caliber and often exclusively of the pigtail-retaining mechanism. Laasch et al\[[@B27]\] used 10.5-French or 12-French "push" gastrostomy catheters and 20-French "pull" gastrostomy catheters in their study. A more recent study used 14.5-French mean-sized "push" gastrostomy catheters and 21-French mean-sized "pull" gastrostomy catheters\[[@B28]\]. Multiple studies have shown that smaller caliber tubes are more prone to either tubal occlusion or failure to meet feeding goals\[[@B24]\]. In addition, Funaki et al\[[@B29]\] reported a much more significant tubal complication rate in pigtail-retaining catheters in the "push" group than mushroom-retaining tubes in the "pull" group (36% *vs* 2%). It has been documented in the literature that larger bore "push" type catheters (20 to 24-French) can be successfully placed *via* the "push" technique. Particularly with moderate conscious sedation the \"push\" technique leads to less patient discomfort compared to the \"pull\" technique during which per oral advancement and manipulation is required. Further, the \"pull\" technique is not ideal for many patients requiring enteral feeding, such as those with head and neck or esophageal tumors as well as postsurgical head and neck patients. In our practice we typically place a 16- or 18-French non-pigtail gastrostomy catheters using the \"push\" technique. It is yet to be determined whether the 16 to 18-French balloon-retaining "push" non-pigtail gastrostomy catheters used at our institution may perform comparably to the mushroom-retained "pull" gastrostomy catheters in those patients who qualify for the \"pull\" technique.

Based our experience the \"push\" technique can be performed faster, is safer in the head and neck patient population, and requires less sedation. Further, it is associated with less patient discomfort as the gastrostomy catheter does not need to be pulled through the mouth. In addition, there is a decreased risk of infection due to a lack of per-oral catheterization with the transition of bacteria from the oral cavity into the gastrointestinal flora or vice versa\[[@B30]\]. Further, the "push" technique minimizes the risks of tumor seeding through the track as opposed to "pull" type gastrostomy catheter placement\[[@B26]\]. Therefore, we prefer to use "push" technique at our institution, although there is still ongoing debate over the most optimal method.

CONCLUSION
==========

Since its inception in 1981, PIRG has gained popularity and has become a viable alternative to the traditional surgical gastrostomy catheter placement. Its technical success and complication rates are comparable to that of PEG and lower than that of surgical placement. The two main types of PIRG include the "push" and "pull" gastrostomy catheter placement techniques. Although both techniques have been established since the late 1990s, there exists a paucity of studies comparing the two. Based on our institutional experience the "push" technique is faster, safer and better tolerated by patients. Its complication rates are comparable to that of the "pull" technique and may be even lower when using larger-bore, balloon-retaining non-pigtail catheters. In this paper we have described in a stepwise fashion our procedural technique and have discussed the perioperative care.
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